458 related articles for article (PubMed ID: 16706806)
41. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
42. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
43. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
44. [Epigenetic alterations in colorectal carcinomas and precancerous lesions].
Tischoff I; Tannapfel A
Z Gastroenterol; 2008 Oct; 46(10):1202-6. PubMed ID: 18937191
[TBL] [Abstract][Full Text] [Related]
45. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
46. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
47. Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas.
Herath NI; Purdie DM; Kew MC; Smith JL; Young J; Leggett BA; MacDonald GA
Int J Oncol; 2009 Nov; 35(5):1081-9. PubMed ID: 19787262
[TBL] [Abstract][Full Text] [Related]
48. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
Esteller M; Herman JG
J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
[TBL] [Abstract][Full Text] [Related]
49. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
50. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
[TBL] [Abstract][Full Text] [Related]
52. Role of epigenetic alterations in cholangiocarcinoma.
Tischoff I; Wittekind C; Tannapfel A
J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
[TBL] [Abstract][Full Text] [Related]
53. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
Yang B; Guo M; Herman JG; Clark DP
Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
[TBL] [Abstract][Full Text] [Related]
54. Chromosomal instability and human hepatocarcinogenesis.
Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K
Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902
[TBL] [Abstract][Full Text] [Related]
55. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
[TBL] [Abstract][Full Text] [Related]
56. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
Derks S; Postma C; Carvalho B; van den Bosch SM; Moerkerk PT; Herman JG; Weijenberg MP; de Bruïne AP; Meijer GA; van Engeland M
Carcinogenesis; 2008 Feb; 29(2):434-9. PubMed ID: 18048385
[TBL] [Abstract][Full Text] [Related]
57. Molecular pathogenesis of human hepatocellular carcinoma.
Thorgeirsson SS; Grisham JW
Nat Genet; 2002 Aug; 31(4):339-46. PubMed ID: 12149612
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
59. Oxidative stress and epigenetic instability in human hepatocarcinogenesis.
Nishida N; Kudo M
Dig Dis; 2013; 31(5-6):447-53. PubMed ID: 24281019
[TBL] [Abstract][Full Text] [Related]
60. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
